"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
Dr. Alaswad reflects on how complex PCI is moving into longer, more calcified, higher-risk cases. Cumulative radiation exposure and the physical toll of protection are becoming career-defining issues. Protecting the team is not optional.
Dr. Alaswad reflects on how complex PCI is moving into longer, more calcified, higher-risk cases. Cumulative radiation exposure and the physical toll of protection are becoming career-defining issues. Protecting the team is not optional.
What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
Brian C. Case, MD; Bailey Ann Richardson, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years.
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years.
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
Key takeaways
Whether immediate coronary angiography should be performed routinely in unconscious patients without an ECG ST-elevation after out-of-hospital cardiac arrest is uncertain due to the lack of data...
Key takeaways
Whether immediate coronary angiography should be performed routinely in unconscious patients without an ECG ST-elevation after out-of-hospital cardiac arrest is uncertain due to the lack of data...
The open-label, noninferiority ISOLEDS trial enrolled 664 patients with true distal left main bifurcation lesions at 24 centres in China and randomised them (1:1) to OCT- or IVUS-guided PCI.
The open-label, noninferiority ISOLEDS trial enrolled 664 patients with true distal left main bifurcation lesions at 24 centres in China and randomised them (1:1) to OCT- or IVUS-guided PCI.
This open-label noninferiority trial was conducted at 25 French centres. Patients aged 80 years or older who were hospitalised with NSTEMI were included. They were randomised to receive either stress imaging-guided selective invasive...
This open-label noninferiority trial was conducted at 25 French centres. Patients aged 80 years or older who were hospitalised with NSTEMI were included. They were randomised to receive either stress imaging-guided selective invasive...
